Backlight and Wurl Partner to Make Streaming Distribution More Seamless and Efficient
Partnership Enables API-first FAST programming with live event insertion across Wurl’s Global Platform BOSTON–(BUSINESS WIRE)–#WeAreBacklight–Global... Read more.
Conduent Implements Technologies to Help South Carolina EBT Cardholders Protect SNAP and Other Benefits from Fraud
The technologies can help agencies and beneficiaries nationwide prevent EBT fraud targeting nutrition assistance and other cash-aid programs FLORHAM PARK, N.J.–(BUSINESS... Read more.
MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
Novartis offers € 68.00 per share in cash, representing a total equity value of € 2.7 billion Shareholders benefit from attractive premium of 94% and 142% on... Read more.
Brian Shimkaveg Appointed Sr. Director of DOD & IC Sales at Rancher Government Solutions
WASHINGTON–(BUSINESS WIRE)–#DoD—Rancher Government Solutions, a leading provider of enterprise Kubernetes management solutions for government agencies,... Read more.
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
Five new launches reinforce Baxter’s focus on differentiated products and enhance the company’s Pharmaceuticals portfolio in critical therapeutic areas Products... Read more.
Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development
TOKYO & NEW YORK & DÜSSELDORF, Germany–(BUSINESS WIRE)–Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced... Read more.
QT Imaging’s Breast Acoustic CT™ Scanner to be Offered at The Center for New Medicine to Advance Personalized Prevention and Detection of Breast Cancer
NOVATO, Calif.–(BUSINESS WIRE)–QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization... Read more.
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China
AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significance as set... Read more.
AnalytixInsight Provides Update on Ongoing Matters
TORONTO–(BUSINESS WIRE)–$ALY.V #AI–AnalytixInsight Inc. (“AnalytixInsight”, or the “Company”) (TSX-V: ALY) today provides additional information... Read more.
Easterly Asset Management Expands Tax-Efficient Solutions with Acquisition of Former Invesco and OppenheimerFunds Rochester Municipal Bond Team
BEVERLY, Mass.–(BUSINESS WIRE)–Easterly Asset Management (“Easterly”), a multi-affiliate asset manager of high-performing boutique investment teams,... Read more.